MoneyTreeTM venture capital funding: Double digit dip

February 2013
  • Print-friendly version
MoneyTree<sup>TM</sup> venture capital funding: Double digit dip

At a glance

Venture capital (VC) funding in the Life Sciences sector, which includes the Biotechnology and Medical Device industries dropped 14% during 2012 but improved at year-end. During the fourth quarter of 2012, investment in the sector rose 11% to $1.9 billion. Download this report to learn more about the trends and what they mean for your business.

Venture capital (VC) funding in the Life Sciences sector, which includes the Biotechnology and Medical Device industries dropped 14% during 2012 but improved at year-end.

According to the MoneyTree Report from PricewaterhouseCoopers (PwC) LLP and the National Venture Capital Association (NVCA) based on data provided by Thomson Reuters, during the fourth quarter of 2012, investment in the sector rose 11% to $1.9 billion from $1.7 billion during the third quarter. The number of life science deals rose 12%, from 187 during the third quarter to 209 during the final quarter of 2012.